|
36.4.20.14 Denileukin Diftitox (Ontak)
Procedure code 1-J9160 is reimbursed by the Texas Medicaid Program for clients with advanced or recurrent cutaneous T-cell lymphoma (payable, but not limited to diagnosis codes 20210 and 20220) with the CD25 component of IL-2 and failure of at least one type of traditional therapy. Documentation of diagnosis and treatment must be submitted with the claim. Denileukin diftitox is reimbursed only when given in the office or outpatient setting.
|
